동물용 백신 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 동물 종류별, 투여 경로별, 유통 채널별, 지역별, 경쟁별(2020-2030년)

The Global Animal Vaccine Market , valued at USD 7.68 Billion in 2024, is projected to experience a CAGR of 8.69% to reach USD 12.66 Billion by 2030. The global animal vaccine market comprises biological preparations designed to stimulate immunity against infectious diseases across various animal species, including livestock and companion animals. These vaccines are crucial for disease prevention, mortality reduction, and public health protection by controlling zoonotic transmission.

Key Market Drivers

The global animal vaccine market is primarily influenced by the rising incidence of zoonotic diseases and the increasing global demand for animal-derived food products. Zoonotic diseases, transmissible between animals and humans, necessitate extensive animal vaccination to mitigate public health risks. For example, according to Forbes, in December 2024, a major mpox epidemic in the Democratic Republic of the Congo and neighboring countries recorded over 16,000 confirmed cases, prompting a public health emergency declaration from the World Health Organization. This underscores the critical role of veterinary vaccines in preventing disease transmission at the human-animal interface.

Key Market Challenges

The substantial cost associated with vaccine research, development, and stringent regulatory approval processes represents a significant impediment to the expansion of the Global Animal Vaccine Market. These extensive financial requirements elevate production expenses, directly impacting vaccine accessibility and affordability, particularly within developing economies where resources are often constrained. The prolonged timelines and complex regulatory pathways demand considerable capital investment, which restricts the number of new vaccines brought to market and limits the capacity for existing ones to be widely distributed at competitive prices.

Key Market Trends

The Global Animal Vaccine Market is significantly influenced by the rapid advancements in next-generation vaccine technologies. This trend encompasses the development of more sophisticated solutions such as recombinant, subunit, and mRNA-based vaccines, moving beyond traditional attenuated or inactivated forms. These innovative vaccines offer enhanced efficacy, improved safety profiles, and often enable faster development cycles and more targeted protection against specific pathogens. According to the World Health Organization's (WHO) 2024 Global Vaccine Market Report, in 2023, 88 vaccine products were sold across 207 countries by 116 manufacturers, underscoring the broad market where technological advancements are being applied.

Key Market Players

• Zoetis Inc.
• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• Biogenesis Bago SA
• Indian Immunologicals Ltd.
• Elanco Animal Health Incorporated
• Phibro Animal Health Corporation
• Neogen Corporation
• Intas Pharmaceuticals Ltd.
• Ouro Fino Saude Animal

Report Scope:

In this report, the Global Animal Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Vaccine Market , By Product:

• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

Animal Vaccine Market , By Animal Type:

• Livestock
• Companion
• Others

Animal Vaccine Market , By Route Of Administration:

• Subcutaneous
• Intramuscular
• Intranasal

Animal Vaccine Market , By Distribution Channel:

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies & Drug Stores
• Others

Animal Vaccine Market , By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Animal Vaccine Market .

Available Customizations:

Global Animal Vaccine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Vaccine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
  • 5.2.2. By Animal Type (Livestock, Companion, Others)
  • 5.2.3. By Route Of Administration (Subcutaneous, Intramuscular, Intranasal)
  • 5.2.4. By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Animal Vaccine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Animal Type
  • 6.2.3. By Route Of Administration
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Animal Vaccine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Animal Type
      • 6.3.1.2.3. By Route Of Administration
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Canada Animal Vaccine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Animal Type
      • 6.3.2.2.3. By Route Of Administration
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Mexico Animal Vaccine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Animal Type
      • 6.3.3.2.3. By Route Of Administration
      • 6.3.3.2.4. By Distribution Channel

7. Europe Animal Vaccine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Animal Type
  • 7.2.3. By Route Of Administration
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Animal Vaccine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Animal Type
      • 7.3.1.2.3. By Route Of Administration
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. France Animal Vaccine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Animal Type
      • 7.3.2.2.3. By Route Of Administration
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. United Kingdom Animal Vaccine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Animal Type
      • 7.3.3.2.3. By Route Of Administration
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Animal Vaccine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Animal Type
      • 7.3.4.2.3. By Route Of Administration
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Animal Vaccine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Animal Type
      • 7.3.5.2.3. By Route Of Administration
      • 7.3.5.2.4. By Distribution Channel

8. Asia Pacific Animal Vaccine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Animal Type
  • 8.2.3. By Route Of Administration
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Animal Vaccine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Animal Type
      • 8.3.1.2.3. By Route Of Administration
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. India Animal Vaccine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Animal Type
      • 8.3.2.2.3. By Route Of Administration
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. Japan Animal Vaccine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Animal Type
      • 8.3.3.2.3. By Route Of Administration
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. South Korea Animal Vaccine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Animal Type
      • 8.3.4.2.3. By Route Of Administration
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. Australia Animal Vaccine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Animal Type
      • 8.3.5.2.3. By Route Of Administration
      • 8.3.5.2.4. By Distribution Channel

9. Middle East & Africa Animal Vaccine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Animal Type
  • 9.2.3. By Route Of Administration
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Animal Vaccine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Animal Type
      • 9.3.1.2.3. By Route Of Administration
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. UAE Animal Vaccine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Animal Type
      • 9.3.2.2.3. By Route Of Administration
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. South Africa Animal Vaccine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Animal Type
      • 9.3.3.2.3. By Route Of Administration
      • 9.3.3.2.4. By Distribution Channel

10. South America Animal Vaccine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Animal Type
  • 10.2.3. By Route Of Administration
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Animal Vaccine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Animal Type
      • 10.3.1.2.3. By Route Of Administration
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Colombia Animal Vaccine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Animal Type
      • 10.3.2.2.3. By Route Of Administration
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. Argentina Animal Vaccine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Animal Type
      • 10.3.3.2.3. By Route Of Administration
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Animal Vaccine Market : SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Zoetis Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Merck & Co., Inc.
• 15.3. Boehringer Ingelheim International GmbH
• 15.4. Biogenesis Bago SA
• 15.5. Indian Immunologicals Ltd.
• 15.6. Elanco Animal Health Incorporated
• 15.7. Phibro Animal Health Corporation
• 15.8. Neogen Corporation
• 15.9. Intas Pharmaceuticals Ltd.
• 15.10. Ouro Fino Saude Animal

16. Strategic Recommendations

17. About Us & Disclaimer